According to relevant literature reports, the ameliorative effects of melatonin and resveratrol on diabetic cardiomyopathy are achieved through the PGC-1α/NRF2 signaling pathway[48,49]. This evidence concerns the gene PPARGC1A and diabetic cardiomyopathy.